infiltrative heart diseases
play

Infiltrative Heart Diseases Mary O. Gray, M.D. Professor of - PDF document

12/19/15 Infiltrative Heart Diseases Mary O. Gray, M.D. Professor of Medicine (Cardiology) UC San Francisco mary.gray@ucsf.edu No Disclosures Increased Left Ventricular Mass and Thick Walls Hypertrophic Hypertension & Cardiomyopathy


  1. 12/19/15 Infiltrative Heart Diseases Mary O. Gray, M.D. Professor of Medicine (Cardiology) UC San Francisco mary.gray@ucsf.edu No Disclosures Increased Left Ventricular Mass and Thick Walls Hypertrophic Hypertension & Cardiomyopathy Kidney Disease Cardiac Mucopoly- Amyloidosis Saccharidosis Cardiac Friedreich Sarcoidosis Ataxia 1

  2. 12/19/15 Endomyocardial Biopsy: Alcian Blue Pathophysiology and Treatment of Cardiac Amyloidosis MA Gertz, A Dispenzieri, and T Sher Nature Reviews Cardiology 12 , 91-102 (2015) 2

  3. 12/19/15 Classification of Cardiac Amyloid Types Amyloidosis Type Precursor Comment Immunoglobulin Light Chain AL Plasma Cell Dyscrasia Light Chain Mutant Transthyretin TTR Point Mutation Autosomal Dominant Wild-Type Transthyretin None Senile Amyloidosis Amyloid A Serum Amyloid A Sustained Inflammation Isolated Atrial Amyloid Atrial Natriuretic Factor Atrial Fibrillation 3

  4. 12/19/15 Serum Free Light Chain Assay Bone Marrow Biopsy: λ Light Chains 4

  5. 12/19/15 Subcutaneous Fat Aspirate: Congo Red Non-Ischemic Cardiomyopathy Serum and Urine Immunofixation. Serum Free Light Chain Assay. Bone Marrow Biopsy and Fat Aspiration with Congo Red Staining Positive AL Likely. Confirm with Mass Spectroscopy. 5

  6. 12/19/15 Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis MA Gertz, MD Benson, PJ Dyck, et al. JACC 2015;66:2451-2466 6

  7. 12/19/15 Transthyretin (TTR) Transporter of Thyroxine and Retinol Non-Ischemic Cardiomyopathy Serum and Urine Immunofixation. Serum Free Light Chain Assay. Negative TTR Wild-Type or Mutant Fat Aspirate Endomyocardial Biopsy Positive Mass Spectroscopy and TTR Gene Sequencing 7

  8. 12/19/15 Evaluation to Diagnose TTR Amyloidosis Results Suggestive of ATTR ✔ Physical Examination Autonomic Neuropathy Serum Immunofixation and ✔ LC Amyloidosis Excluded Immunoglobulin Free LC Assay ✔ Urine Tests Nephrotic Range Proteinuria Tissue and Strain Doppler ✔ Diastolic Dysfunction Echocardiography ✔ Cardiac Magnetic Resonance Chamber Infiltration Results Suggestive of ATTR ✔ Radionuclide Imaging Cardiac Amyloid Detection Elevated Troponin ✔ Cardiac Biomarkers Brain Natriuretic Peptide ✔ Medical History Carpal Tunnel Syndrome ✔ Tissue Biopsy: less invasive Fat and Bone Marrow ✔ Tissue Biopsy: more invasive Heart, Nerve, Kidney ✔ Mass Spectroscopy TTR Amyloid Deposits 8

  9. 12/19/15 CMR without Gadolinium: Wall Thickening Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis M Fontana, S Pica, P Reant, et al. Circulation 2015;132:1570-1579 9

  10. 12/19/15 CMR with Late Gadolinium Enhancement LGE Pattern and Cardiac Amyloid Burden 10

  11. 12/19/15 LGE Pattern and Cumulative Survival Hypothesis: Cardiac Amyloid Progression 11

  12. 12/19/15 Heart Failure with Preserved Ejection Fraction HFpEF Therapy and Cardiac Amyloidosis ✔ Loop Diuretic Volume Status ✔ ACE Inhibitor or ARB Blood Pressure ✔ Beta Blocker Cardiac Output ✔ Calcium Channel Blocker Cardiac Output 12

  13. 12/19/15 Arrhythmias and Cardiac Amyloidosis ✔ Amiodarone Effective ✔ Anticoagulation Effective ✔ Cardioverter-Defibrillator Possible Benefit ✔ Revascularization Possible Benefit A European Collaborative Study of Cyclophosphamide, Bortezomib, and Dexamethasone in Upfront Treatment of Systemic AL Amyloidosis G Palladini, S Sachchithanantham, et al. Blood 2015;126(5):612-615 13

  14. 12/19/15 AL Cardiac Stage and Survival after CyBorD Therapeutic Clearance of Amyloid by Antibodies to Amyloid P Component DB Richards, LM Cookson, AC Berges, et al. NEJM 2015;373:1106-1114 14

  15. 12/19/15 99m Technetium Imaging of Wild-Type TTR Amyloid Scintigraphy Scan SPECT Imaging Response to CPHC and Anti-SAP Antibody 15

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend